The U.S.-led BioIndustrial Manufacturing and Design Ecosystem (BioMADE) initiative, launched in 2020 by the U.S. Department of Defense, is expanding its operations to Iowa. BioMADE, a nonprofit organization under the Engineering Biology Research Consortium (EBRC), aims to advance sustainable and reliable bioindustrial manufacturing technologies. With an initial $87 million award from the Department of Defense, BioMADE is establishing a Manufacturing Innovation Institute (MII) headquartered at the University of Minnesota to collaborate with public and private entities.
BioMADE’s recent announcement outlines plans to construct a pilot-scale bioindustrial manufacturing facility near Ames, Iowa. This facility is part of BioMADE’s Pilot Plant Network, which includes facilities in Minnesota and California. The goal of these facilities is to position the U.S. as a global leader in the bioeconomy, enhance domestic supply chains for defense and commercial products, and drive rural economic development. The Ames facility, spanning 15,000 square feet, will house up to 10,000-liter industrial fermenters, lab space, and downstream processing capabilities for agricultural bioproducts, chemicals, and food.
The $40 million project in Iowa will see BioMADE investing at least $20 million, with additional funding from Iowa State University (ISU) and the Iowa Economic Development Authority’s Strategic Infrastructure Program. By addressing the current infrastructure challenges in the bioindustrial manufacturing industry, BioMADE aims to establish a network of pilot- and demonstration-scale facilities across the U.S. to accelerate technological development and scale-up processes. The Ames facility will complement existing infrastructure in Iowa, such as ISU’s Center for Crops Utilization Research, to facilitate faster commercialization of biomanufactured products.
Governor Kim Reynolds of Iowa expressed pride in partnering with BioMADE to spearhead the next generation of biomanufacturing infrastructure. The facility in Ames is expected to leverage Iowa’s agricultural resources, create high-quality jobs, and drive innovation in bioscience. Dr. Douglas Friedman, CEO of BioMADE, highlighted the significance of the Iowa facility in bolstering biomanufacturing capabilities nationwide and acknowledged Governor Reynolds for her support. Industry leaders, such as Colleen May from Cargill’s Bioindustrials Group, emphasized the critical role of scale-up facilities like the one in Iowa in advancing biomanufacturing and supporting industry growth.
In parallel developments, BioMADE has also established sites in Minnesota and California as part of its nationwide network. The facility in Hayward, California, operated in partnership with Lygos, a sustainable specialty chemicals company, is focused on expanding biomanufacturing infrastructure to support defense and consumer applications. In Minnesota, the Maple Grove facility aims to enhance the state’s position in sustainability innovation and bioindustrial manufacturing. These initiatives underscore BioMADE’s commitment to strengthening U.S. capabilities in biotechnology and biomanufacturing while fostering economic growth and job creation.
The expansion of the BioMADE initiative to Iowa, California, and Minnesota signifies a strategic investment in bioindustrial manufacturing infrastructure in the U.S. by addressing key challenges in scaling up biomanufacturing processes. Through collaboration with public and private partners, BioMADE is paving the way for innovation, job creation, and economic development in the biotech sector. The establishment of pilot-scale facilities like the one in Ames, Iowa, represents a crucial step towards realizing the full potential of biomanufacturing technologies in the U.S.
Key Takeaways:
– The U.S.-led BioMADE initiative is expanding its bioindustrial manufacturing infrastructure to Iowa, California, and Minnesota.
– BioMADE’s pilot-scale facilities aim to accelerate the development and commercialization of biomanufactured products.
– The establishment of the Ames facility in Iowa highlights the state’s commitment to leading in biomanufacturing innovation and economic development.
– Collaboration between BioMADE, government entities, and industry stakeholders is driving advancements in sustainable bioindustrial manufacturing technologies.
Tags: pilot plant, downstream, biotech
Read more on businessfacilities.com